top of page

Neurofibromatosis

Introduction

A group of genetic conditions leading to tumours arising from nerve tissue
- Depending on the manifestation (1,2,3) will have different aetiologies and manifestations.
- NF1 is most common, ~1 in every 2500, 3000 people in Australia
- NF2 is rare, with ~1 in every 25,000 to 40,000 people being afflicted.
- Schwannomatosis is rare, typically appearing in people over 30 years of age.
- ~15% inherited and ~1 in 40,000 people
- All affect populations regardless of ethnicity or gender, and many features to not appear until later childhood or early adulthood, and variable expression and severity

Dead Giveaways

Neurofibromatosis 1:

  • Due to a defect in the NF1 gene on chromosome 17q11 damaging neurofibromin 1

  • For a diagnosis to be made, it must possess 2 of the 7 following criteria:

    • Six or more cafe-au-lait spots

      • >5mm in pre-pubertal children

      • >15mm in post-pubertal children


      • The cafe-au-lait spots
        The cafe-au-lait spots
    • 2 or more Lisch Nodules of the iris.

      • Seen typically from the 2nd or 3rd decade as translucent or pigmented nodules (<3mm)

      • The Lisch Nodule Dots
        The Lisch Nodule Dots
    • 2 or more neurofibromas of any type, or one plexiform neurofibroma

      • Neurofibromas appear at puberty as pedunculated and flabby nodules

        • Increases number with life, often widely distributed, internally and externally

        • Cutaneous neurofibromas are soft skin-coloured to purple nodules that may become pedunculated as they grow

        • Usually develop in late adolescence and found in vast majority of Px with NF1

        • Can have few lesions to thousands. They are benign with no risk of malignancy, but are very uncomfortable and have cosmetic disfigurement

        • Solitary neurofibroma
          Solitary neurofibroma

      • Plexiform neurofibromas present in 30% of NF1, affecting the more complex nerve plexuses and can lead to eyelid neurofibromas which can cause mechanical ptosis.

        • Associated with glaucoma

        • Neurofibromas infiltrate the anterior angle, leading to secondary angle closure, since the neurofibromas cause ciliary body and choroidal thickening, along with ectropion uveae and endothelialisation of angle

        • Fibrovascularisation can cause synechial angle closure and neovascular glaucoma.

        • Developmental angle abnormalities

    • Freckling in the axilla or groin

    • Optic pathway glioma

      • Represents ~70% of all ON sheath tumours; can arise within optic pathways, ON, optic tract and brainstem.

      • ~15-20% of children with NF-1 will develop an optic pathway glioma

      • A benign slow growing tumour.

      • ~30% of optic pathway glioma Px have NF1 and bilateral optic pathway gliomas are diagnostic for NF1

      • Children aged <6y with NF1 are most at risk

    • Distinct bony lesion

      • Bone defect in orbital wall (sphenoid), or bowing of long bones in legs. etc.

    • A 1st degree relative with NF1 with above criteria

  • Choroidal Nodules


Neurofibromatosis 2:

Associated with certain clinical features:

  • hearing loss/tinitius/imbalance

  • Bilateral acoustic neuromas (schwannomas) from schwann cells around nerves)

  • 1st degree relative with NF2 with unilateral acoustic neuroma + any 2 of the following:

    • Meningioma

    • Glioma

    • Schwannomas of other nerves

    • Early onset cataracts

    • Combined hamartoma of retina/RPE

  • Ophthalmic Features:

    • Cataracts before age 30

    • Fundus lesions like hamartomas, perifoveal epiretinal membrane

    • Ocular motor problems (~10%)

    • Others like optic pathway glioma, ON sheath meningioma


Schwannomatosis (NF3):

  • Benign tumour composed of Schwann cells.

  • Unlike NF2, doesn't develop vestibular tumours

  • Growth of multiple Schwannomas throughout body causes chronic intense pain

  • Can have unilateral vestibular schwannomas sometimes, but not bilateral (NF2)

diagnostic features

Optic Pathway Glioma Signs/Symptoms:

  • Proptosis

  • Vision loss

  • Optic atrophy

  • Optic nerve oedema

  • Slow vision loss that can remain stable in ~80% of patients.

  • VF changes can also manifest


NF3 Symptoms/Signs:

  • Extreme intense pain; tumours growing and presses on nerves or nearby tissue

  • Numbness, tingling or weakness in fingers and toes

  • Vision changes

  • Headaches


Prognosis

  • Life expectancy greatly reduced for Px with NF1 and 2

  • Principal causes of early death with NF1

    • Complication of systemic hypertension, expansive growth of benign intracranial tumours

    • Several types of cancer including neurofibrosarcoma, other sarcomas, leukemias, and lymphomas occur with increase frequency in NF1

  • In NF2, the main cause of death comes from the expansion of the CNS tumour.

  • Unilateral or bilateral blindness: usually optic pathway glioma; occasionally related to intracranial vestibular schwannoma

2025, made by Eric Qin. UNSW. SOVS

bottom of page